Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study. : J Acquir Immune Defic Syndr

Archive ouverte

Petoumenos, K. | Kuwanda, L. | Ryom, L. | Mocroft, A. | Reiss, P. | de Wit, S. | Pradier, C. | Bonnet, Fabrice | Phillips, A. | Hatleberg, C. I. | d'Arminio Monforte, A. | Weber, R. | Sabin, C. A. | Lundgren, J. | Law, M. G.

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. BACKGROUND: Weight gain is common among people with HIV once antiretroviral treatment (ART) is commenced. We assess the effect of changes in body mass index (BMI), from different baseline BMI levels, on the risk of cardiovascular disease (CVD) and diabetes mellitus (DM). METHODS: D:A:D participants receiving ART were followed from their first BMI measurement to the first of either CVD or DM event, or earliest of 1/2/2016 or 6 months after last follow-up. Participants were stratified according to their baseline BMI, and changes from baseline BMI were calculated for each participant. Poisson regression models were used to assess the effects of changes on BMI on CVD or DM events. RESULTS: There were 2,104 CVD and 1,583 DM events over 365,287 and 354,898 person years (rate: CVD 5.8/1000 (95% CI 5.5-6.0); DM 4.5/1000 (95% CI 4.2 - 4.7)). Participants were largely male (74%), baseline mean age of 40 years and median BMI of 23.0 (IQR: 21.0-25.3). Risk of CVD by change in BMI from baseline, stratified by baseline BMI strata showed little evidence of an increased risk of CVD with an increased BMI in any baseline BMI strata. An increase in BMI was associated with an increased risk of DM across all baseline BMI strata. CONCLUSIONS: While increases in BMI across all levels of baseline BMI were not associated with an increased risk of CVD, such changes were consistently associated with increased risk of DM. There was also some evidence of an increased risk of CVD with a decrease in BMI.

Consulter en ligne

Suggestions

Du même auteur

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. : Clin Infect Dis

Archive ouverte | Shepherd, L. | CCSD

International audience. Background. Cancers are a major source of morbidity and mortality for human immunodeficiency virus (HIV)-infected persons, but the clinical benefits of smoking cessation are unknown. Methods....

Associations between serum albumin and serious non-AIDS events among people living with HIV. : AIDS

Archive ouverte | Ronit, A. | CCSD

International audience. OBJECTIVE: Lower serum albumin (sAlb) has been associated with an increased risk of mortality and AIDS among people living with HIV and may be associated with the development of serious non-A...

Abacavir use and risk of recurrent myocardial infarction. : AIDS

Archive ouverte | Sabin, C. A. | CCSD

International audience. OBJECTIVE: To investigate the association between abacavir (ABC) use and recurrent myocardial infarction (MI) among HIV-positive people with a prior MI. DESIGN: International multicohort coll...

Chargement des enrichissements...